3 Biotech Growth Stocks Near Highs

By ONeil Trader

You can always find growth opportunities in the biotech sector. I have picked out three biotech stocks with solid fundamentals, compelling growth and prices near all-time highs. Some are introducing new drugs and some are boosting growth through acquisitions.

Celgene Corporation

Celgene Corporation (CELG), a biopharmaceutical company, discovers, develops, and commercializes various therapies to treat cancer and immune-inflammatory related diseases primarily in the United States and Europe, according to Yahoo Finance. Some of the company’s commercial stage products include: Revlimid, Vidaza, Thalomid, Abraxane, Istodax, and it has various preclinical and clinical-stage products.

The company delivered solid and stable growth in recent quarters, and was beating estimates and raising guidance. Earnings growth has ranged from 26% to 43% in previous four quarters, and revenue was up 13% to 18% in the same time period. Trailing PE is 26.69 and forward PE is 17.23, and the PEG ratio is 0.88 according to Yahoo Finance. Earnings growth was 34% in the last five years, and projected 5-year growth is 22%. Analyst EPS forecast has been trending up in the last 90 days, from 1.30 to 1.31 for the current quarter, and from 5.53 to 5.59 for the next year…..

For full story visit: seeking alpha

Share This Post

Recent Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS